Anip stock forecast

ARCT Arcturus Therapeutics Ltd — Stock ... - StockTwits

BPAX Stock Quote - ANI Pharmaceuticals Inc - Bloomberg Markets Stock analysis for ANI Pharmaceuticals Inc (BPAX) including stock price, stock chart, company news, key statistics, fundamentals and company profile. NASDAQ:ANIP ANI Pharmaceuticals Inc Stock Analysis ... ANI Pharmaceuticals, Inc. is a pharmaceutical company which develops, manufactures and markets prescription pharmaceuticals in the U.S. Its areas of product development currently include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products.

10 Mar 2020 Unfortunately for some shareholders, the ANI Pharmaceuticals (NASDAQ:ANIP) share price has dived 38% in the last

ANIP ANI Pharmaceuticals, Inc. — Stock ... - StockTwits Apr 02, 2020 · Real-time trade and investing ideas on ANI Pharmaceuticals, Inc. ANIP from the largest community of traders and investors. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. ANIP Stock Quote - ANI Pharmaceuticals, Inc. Price - Nasdaq Stock quote for ANI Pharmaceuticals, Inc. Common Stock (ANIP) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. ANI Pharmaceuticals Inc - ANIP - Stock forecast - 3 months ... Aug 20, 2019 · ANIP stock forecast Our latest prediction for ANI Pharmaceuticals, Inc.'s stock price was made on the Aug. 20, 2019 when the stock price was at 67.36$. In the short term (2weeks), ANIP's stock price should outperform the market by 0.68%. During that period the price should oscillate between -5.38% and +6.98%.

Find real-time ARWR - Arrowhead Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business.

ARCT Arcturus Therapeutics Ltd — Stock ... - StockTwits Securities products and services offered to self-directed investors through ST Invest, LLC. Member FINRA / SIPC.ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Please read important legal disclosures. HIIQ Price Target | Health Insurance Innovations Stock ... See Health Insurance Innovations price target based on 4 analysts offering 12 month price targets for Health Insurance Innovations in the last 3 months. The average price target is $53.50 with a high forecast of $80.00 and a low forecast of $40.00. ANI Pharmaceuticals Inc., ANIP Quick Chart - (NAS) ANIP ... ANIP - ANI Pharmaceuticals Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. ANI Pharmaceuticals started at strong buy with $68 stock price target at Raymond James MarketWatch. Tuesday, September 22, 2015. Industry Analysis and Future Forecast till 2025 By Leading Players: Akorn ,Zydus Mallinckrodt plc (MNK) Stock Price, Quote, History & News ...

Pacira BioSciences, Inc. (PCRX) Stock Price, Quote ...

ANIP Stock Price | ANI Pharmaceuticals Inc. Stock Quote (U ... ANIP | Complete ANI Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. ANIP ANI Pharmaceuticals, Inc. — Stock ... - StockTwits

Benjamin Graham Guru Analysis of ANI Pharmaceuticals, Inc ...

Real time ANI Pharmaceuticals (ANIP) stock price quote, stock graph, news & analysis. ANI Pharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. View live ANI PHARMACEUTICALS INC chart to track its stock's price action. Find market predictions, ANIP financials and market news. 10 Mar 2020 Unfortunately for some shareholders, the ANI Pharmaceuticals (NASDAQ:ANIP) share price has dived 38% in the last

NASDAQ ANIP opened at $42.92 on Wednesday. The stock has a 50-day simple moving average of $59.65 and a two-hundred day simple moving average of $64.49. The firm has a market capitalization of $524.19 million, a P/E ratio of 9.45 and a beta of 1.98. ANI Pharmaceuticals Inc (NASDAQ:ANIP) Receives Average ...